IBB Stock UPDATES Nasdaq Biotechnology Ishares (IBB) 296.62 11/02/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Nasdaq Biotechnology Ishares (IBB) 296.62 $IBB

Watch for iShares Nasdaq Biotechnology Index to Potentially Pullback After Gaining 1.21% Yesterday
Comtex SmarTrend(R) - Tue Oct 28, 4:27PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $291.52 to a high of $294.65. Yesterday, the shares gained 1.2%, which took the trading range above the 3-day high of $290.44 on volume of 1.6 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
IBB: 296.62 (-0.08)

SmarTrend Watching for Potential Pullback in Shares of iShares Nasdaq Biotechnology Index After 1.21% Gain
Comtex SmarTrend(R) - Tue Oct 28, 4:27PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $291.52 to a high of $294.65. Yesterday, the shares gained 1.2%, which took the trading range above the 3-day high of $290.44 on volume of 1.6 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
IBB: 296.62 (-0.08)

After Yesterday's Rally of 2.66% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Thu Oct 23, 4:13PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $277.90 to a high of $285.23. Yesterday, the shares gained 2.7%, which took the trading range above the 3-day high of $278.81 on volume of 1.9 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
IBB: 296.62 (-0.08)

SmarTrend Watching for Potential Pullback in Shares of iShares Nasdaq Biotechnology Index After 2.66% Gain
Comtex SmarTrend(R) - Thu Oct 23, 4:12PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $277.90 to a high of $285.23. Yesterday, the shares gained 2.7%, which took the trading range above the 3-day high of $278.81 on volume of 1.9 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
IBB: 296.62 (-0.08)

Are Blue-Chip Stocks Past Their Prime or Still Worth Owning?
at The Street - Thu Oct 23, 3:15PM CDT
The 'Fast Money' trading panel looks at which blue-chip stocks investors should own, as well as at the overall stock market.
MMM: 153.77 (+1.67), GE: 25.81 (+0.14), HON: 96.12 (+0.53), NKE: 92.97 (-0.03), PRU: 88.54 (+1.05), UTX: 107.00 (+0.66), XBI: 171.39 (-1.98), SKX: 54.75 (-0.41), IBB: 296.62 (-0.08), KKR: 21.56 (+0.13), INTC: 34.01 (+1.43), UPS: 104.91 (+1.62), SPY: 201.66 (+2.28), IBM: 164.40 (+0.05), DIA: 173.45 (+1.85), DAN: 20.46 (+0.36), CAT: 101.41 (+1.25), MSFT: 46.95 (+0.90), KO: 41.88 (+0.48), IR: 62.62 (+0.89), DIS: 91.38 (+1.16), CLF: 11.23 (+0.73), WLT: 2.41 (+0.12), UA: 65.58 (+1.35), FTNT: 26.05 (+0.31)

3 Stocks I'll Buy if the Market Crashes
George Budwell, The Motley Fool - Motley Fool - Mon Oct 20, 12:01PM CDT
After a monstrous bull run of late, the stock market finally started to pullback. The Nasdaq Biotechnology Index , for instance, fell by nearly 7% last week alone: Even so, it's important to keep the magnitude of this week's drop in...
ACAD: 27.70 (-0.35), GILD: 112.00 (-2.22), SHPG: 199.80 (+0.38), NPSP: 27.40 (-1.06), IBB: 296.62 (-0.08), ABBV: 63.46 (+2.28)

Look for Shares of iShares Nasdaq Biotechnology Index to Potentially Pullback after Yesterday's 1.68% Rise
Comtex SmarTrend(R) - Fri Oct 17, 4:13PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $263.11 to a high of $268.03. Yesterday, the shares gained 1.7%, which took the trading range above the 3-day high of $264.14 on volume of 1.7 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
IBB: 296.62 (-0.08)

IBB, GULF, GDP, DBOEY, Added To Naked Short Lists Today
M2 - Mon Oct 13, 10:51AM CDT
BUYINS.NET, www.buyins.net , announced today that these select companies have been Added To the NASDAQ, AMEX, NYSE, OTCBB and Pinksheet naked short threshold lists. Ishares Nasdaq Biotechnology (NASDAQ:IBB), WisdomTree Middle East Dividend Fund (NASDAQ:GULF), Goodrich Petroleum Corp (NYSE:GDP), Deutsche Boerse AG (OTC BOEY). For a complete list of companies on the naked short lists please visit our web site. To find the SqueezeTrigger Price before a short squeeze starts in any stock, go to http://www.buyins.net .
GDP: 8.24 (-0.02), GULF: 23.07 (+0.06), IBB: 296.62 (-0.08)

iShares Nasdaq Biotechnology Index Set to Possibly Rebound After Yesterday's Selloff of 2.09%
Comtex SmarTrend(R) - Fri Oct 10, 4:47PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $262.08 to a high of $271.25. Yesterday, the shares fell 2.1%, which took the trading range below the 3-day low of $264.52 on volume of 1.9 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
IBB: 296.62 (-0.08)

After Yesterday's Decline of 2.09%, iShares Nasdaq Biotechnology Index Offers Investors Better Value
Comtex SmarTrend(R) - Fri Oct 10, 4:47PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $262.08 to a high of $271.25. Yesterday, the shares fell 2.1%, which took the trading range below the 3-day low of $264.52 on volume of 1.9 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
IBB: 296.62 (-0.08)

'Fast Money' Recap: Relief About the Stock Market Rally
at The Street - Thu Oct 09, 4:00AM CDT
The trading panel discussed where they are putting their money after the change in market direction.
F: 14.09 (+0.14), LMT: 190.57 (+1.28), ARWR: 6.52 (-0.21), XOP: 60.87 (+1.70), XBI: 171.39 (-1.98), C: 53.53 (+0.38), M: 57.82 (-0.08), IBB: 296.62 (-0.08), SHLD: 34.92 (-1.82), AA: 16.76 (+0.54), TJX: 63.32 (+0.07), RIG: 29.83 (+0.34), GILD: 112.00 (-2.22), GLD: 112.66 (-2.53), TGT: 61.82 (+0.04), JCP: 7.61 (-0.02), GM: 31.40 (+0.62), GOOGL: 567.87 (+7.60), GPS: 37.89 (+0.02), TWTR: 41.47 (-0.33), XLE: 87.42 (+1.74)

'Fast Money' Recap: What Should You Buy in a Declining Market?
at The Street - Wed Oct 08, 4:00AM CDT
The trading panel discusses Yum! Brands, the mining industry and Ebola treatments.
PEI: 21.43 (+0.21), CLR: 56.37 (+1.25), GMCR: 151.75 (+1.77), TKMR: 16.68 (-0.26), IBB: 296.62 (-0.08), M: 57.82 (-0.08), JBLU: 11.54 (+0.36), UPS: 104.91 (+1.62), PEP: 96.17 (+0.52), SBUX: 75.56 (-1.76), AGN: 190.06 (+0.62), SAVE: 73.11 (+2.21), CMRX: 31.04 (+1.15), EOG: 95.05 (+2.83), DPZ: 88.79 (-0.09), COST: 133.37 (+0.37), GOOGL: 567.87 (+7.60), CMLS: 3.86 (+0.24), AAPL: 108.00 (+1.02), MBLY: 52.01 (+1.11), YUM: 71.83 (+1.85), APC: 91.78 (+2.32), AMBA: 44.29 (+2.49), AEC: 19.53 (+0.42), GPRO: 77.10 (+8.85), ETN: 68.39 (+1.62), IR: 62.62 (+0.89), GSK: 45.49 (+0.35), PXD: 189.06 (+3.70), MCD: 93.73 (+0.35), GM: 31.40 (+0.62), IWM: 116.56 (+1.69), SODA: 22.04 (+0.28)

Why Is George Soros Buying Celgene Corporation?
George Budwell, The Motley Fool - Motley Fool - Mon Oct 06, 9:01AM CDT
Superinvestors have transcended the investing landscape for one simple reason: they are awfully good at making money. Many smaller investors therefore like to track the movements of these "elephants" to see what they are buying and selling in hopes...
IBB: 296.62 (-0.08), CELG: 107.09 (+0.15)

The Complete Guide to Biotech ETFs - ETF News And Commentary
Zacks Equity Research - Zacks Investment Research - Thu Oct 02, 11:09AM CDT
Biotech sector appears to be back on track with fundamentals remaining attractive.
PBE: 49.89 (-0.19), FBT: 99.46 (+0.20), XBI: 171.39 (-1.98), BBH: 115.77 (-0.08), IBB: 296.62 (-0.08)

SmarTrend Watching for Potential Rebound in Shares of iShares Nasdaq Biotechnology Index After 1.50% Loss
Comtex SmarTrend(R) - Wed Oct 01, 4:11PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $267.58 to a high of $273.65. Yesterday, the shares fell 1.5%, which took the trading range below the 3-day low of $272.22 on volume of 2.0 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
IBB: 296.62 (-0.08)

'Fast Money' Recap: How to Trade After the Market's Drop
at The Street - Fri Sep 26, 4:00AM CDT
The trading panel likes the idea of buying Microsoft, Intel and other tech stocks if the market opens lower Friday
BIIB: 321.08 (+0.08), NKE: 92.97 (-0.03), XBI: 171.39 (-1.98), BBRY: 10.50 (+0.02), IBB: 296.62 (-0.08), INTC: 34.01 (+1.43), YHOO: 46.05 (+0.42), DD: 69.15 (+1.49), GOOGL: 567.87 (+7.60), MSFT: 46.95 (+0.90), AAPL: 108.00 (+1.02), REGN: 393.72 (+0.92), AMZN: 305.46 (+6.39), MU: 33.09 (+1.27), VRTX: 112.64 (+1.79), EMN: 80.78 (+5.01), FB: 74.99 (+0.88), BRCM: 41.88 (+1.19), PFE: 29.95 (+0.11), AMGN: 162.18 (+0.60), TIF: 96.12 (+0.86), HPQ: 35.88 (+0.56), PCLN: 1,206.21 (+59.62), LULU: 41.65 (-0.03), MHR: 4.64 (+0.04), GILD: 112.00 (-2.22), FNV: 46.75 (-1.66), RGLD: 57.15 (-2.49), IWM: 116.56 (+1.69), DOW: 49.40 (+1.15), BABA: 98.60 (-0.13), AN: 57.26 (+1.36)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 230

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
DIRECTV Bags New NHL Deals: Stakes for Sports Fans

Updated Category News Views 308

NHL Fans, Strap in: DIRECTV Expands Its Lineup In a world where keeping up with your favorite team gets tougher each day, DIRECTV just lobbed a puck right into the net with their latest play. They've snagged a multi-year deal with the NHL for the Carolina Hurricanes, Columbus Blue Jackets, Minnesota Wild, and St. Louis Blues networks. It's a game changer, folks. If you...

Continue Reading
Spooky Dining at CARNE: A Halloween Hit in Oxnard

Updated Category News Views 242

A Festive Transformation at CARNE Rolling into Oxnard, you're met with an unconventional dining spectacle at CARNE. It's not your average restaurant fare as they've pulled out the stops with their spirited Halloween pop-up, A Nightmare at CARNE. Channeling the eerie charm of "The Nightmare Before Christmas," this temporary transformation morphs the venue into a lively,...

Continue Reading
Fluence Energy Hits Legal Snag: Investors Called to Act

Updated Category News Views 22

Fluence Energy Faces a Securities Fraud Challenge It's like watching a slow-motion train wreck. Fluence Energy, Inc. (NASDAQ: FLNC) now finds itself in the crosshairs of a securities fraud class action lawsuit. Apparently, someone was playing fast and loose with the truth concerning their financial guidance. The period in question stretches from November 24, 2025, to...

Continue Reading
Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

Updated Category News Views 134

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Continue Reading
Monster Energy Unleashes Gaming Frenzy at Cosm L.A. Event

Updated Category News Views 96

Where Energy Drinks and Digital Reality Collide Monster Energy sure knows how to throw a party, especially when it hinges on something as electrifying as Call of Duty: Modern Warfare 4. Imagine this: Cosm Los Angeles is decked out with a massive 87-foot LED dome, and every gamer, celeb, and influencer ready to dive right in. You can't make this stuff up. They've mashed...

Continue Reading
Community in Shock After Fatal Bakersfield Shooting

Updated Category News Views 0

The Ripple Effect of Tragedy Grief has a way of shaking a community down to its core—especially when the loss emanates from such senseless violence as the shooting death of 17-year-old Levi Brown. This wasn't just a tragic occurrence at a Friday night football game in Bakersfield; it was a visceral crack in the perceived safety of community events. Levi's Legacy and...

Continue Reading
Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Updated Category News Views 252

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Continue Reading
Innovent's IBI3001 Shows Promise in Phase 1 Trials

Updated Category News Views 225

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Continue Reading
Axon Body 5: A Leap Forward in AI for Public Safety

Updated Category News Views 336

Axon Raises the Stakes with Body 5 Camera Boy, oh boy, Axon's dropped a bombshell with the Body 5. We're talking a colossal leap into the AI era for public safety, and if you're in the biz, you can't just shrug this one off. We're looking at 25 times the AI processing power compared to Axon's old units. That's right, I said twenty-five. Real-time situational awareness in...

Continue Reading

Top 5 Most Recently Viewed Articles

Kinetic Seas Incorporated Secures First Customer Success

Updated Category News Views 56

Kinetic Seas Incorporated Secures First Customer and Financial Growth Kinetic Seas Incorporated (OTC: ECGR) is excited to announce the signing of its first customer, along with impressive revenue results for the second quarter. This milestone marks a significant step forward as the company pursues its goals in the artificial intelligence sector. Second Quarter Revenue...

Continue Reading
Webinar Guide for Veterans to Maximize Benefits Offered by CCK Law

Updated Category News Views 134

Helping Veterans Discover VA Benefits with a Free Webinar Chisholm Chisholm & Kilpatrick LTD (CCK Law), a preeminent veterans disability law firm, is excited to introduce a free, on-demand webinar aimed at assisting veterans in uncovering valuable VA benefits that many may be unaware of. Insights from the Experts The webinar, dubbed "Biggest Benefits Veterans Overlook,"...

Continue Reading
Tech Market Shifts: Navigating Opportunities and Challenges Ahead

Updated Category News Views 161

Understanding Recent Market Dynamics In recent weeks, global markets have been experiencing heightened volatility, particularly in the technology sector. With various significant events unfolding—including new political leadership in Japan and shifts in economic data—investors are carefully analyzing these developments to navigate potential risks and opportunities....

Continue Reading
Michael Beland Joins Advance Auto Parts as Chief Accounting Officer

Updated Category News Views 720

Welcome Michael Beland to Advance Auto Parts Advance Auto Parts, Inc. (NYSE: AAP), known for its significant role in the automotive aftermarket, recently made an important announcement regarding its executive leadership. The company has appointed Michael Beland as the new senior vice president, controller, and chief accounting officer, marking a pivotal addition to their...

Continue Reading
Recall Movement Against Governor Newsom Gains Momentum

Updated Category News Views 276

Recall Movement Gains Traction in California In an unprecedented move, SavingCalifornia.vote has taken a significant step to initiate a recall against Governor Gavin Newsom. This initiative marks a pivotal moment in California's political landscape. The organization is gathering support and will soon submit the official notice of intent to recall, alongside the necessary...

Continue Reading